Despite Tariff Easing Trust Deficit Persists for Chinese Firms in US Market UK Social Media Regulation Risk Intensifies as Starmer Vows Action Following Meeting with Bereaved Parents Burberry Shares Climb on Report of Potential Moncler Takeover Bid Qualcomm Stock Surges as Investor Optimism Grows Over AI Device Boom VinFast Founders Son Takes Helm as EV Maker Adjusts Global Strategy Qatar Holding Sells 48 Lakh Shares in Adani Energy Solutions Birla Mutual Fund Acquires Stake BY Q1 2026 Earnings EPS Beat With 755 Surprise Shares Edge Higher TXG Q1 2026 Earnings EPS Beat Masks Revenue Uncertainty as Stock Declines DXR Q3 2007 Earnings Earnings Per Share Surges Past Estimates XOMA Royalty Corporation Q1 2026 Earnings EPS Misses Estimates Royalty Revenues Under Scrutiny Offerpad Solutions Inc OPAD Q1 2026 Earnings Narrower Loss Beats Estimates as Cost Controls Drive Beat OCUL Q1 2026 Earnings WiderThanExpected Loss as Ocular Therapeutix Advances Pipeline CCID Preferred Shares Edge Lower Key Support and Resistance Levels in Play Teladoc Health TDOC Holds Steady at 657 Consolidation Near Key Support Piedmont Realty Trust PDM Holds Near Support After Modest Gain Top Wealth Group Holding TWG Holds Near Support Amid Slight Decline Manchester United Shares Slip Amid Performance Concerns Citi Highlights Two Catalysts That Could Drive SanDisk Stock Higher Arcturus Therapeutics Holdings Inc ARCT Q1 2026 Earnings Narrower Net Loss Beats Estimates Amid Pipeline Progress RTX Corporation RTX Gains Over 2 Defense Sector Momentum Drives Price Toward Resistance CSV Q1 2026 Earnings EPS Beats Estimate Amid Tight Beat Stock Slips 2 CMCT Q3 2024 Earnings Significant EPS Miss Highlights Challenges Yet Stock Advances BBWI Q1 2026 Earnings EPS Surpasses Expectations Shares Rally AIM ImmunoTech Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment American Integrity Insurance Group AII Q1 2026 Earnings EPS Slightly Exceeds Estimates in a Steady Underwriting Environment TME Q1 2026 Earnings Slightly Beats Estimates as Shares Rise 45 CNTX Q1 2026 Earnings Context Therapeutics Beats EPS Estimates with NarrowerThanExpected Loss